BioPharma M&A: Keys to Success
|Comments are Off
WATCH THIS PROGRAM ON-DEMAND / CLICK HERE FOR COMPLIMENTARY ACCESS Over the first half of 2019, a staggering $170B has been pledged to biopharma buyout activities, an amount that exceeds the total deal spend of the last three years combined. With the increasing complexity and...